Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - CASH FROM OPERATIONS
Cash from Operations DNLI - Denali Therapeutics Inc.
-358 M
LAST VALUE
-30.14%
2 YEAR CAGR
-52.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR